SCHEMBL6133356

SCHEMBL6133356

CCn1nc(-c2sc(C(=O)NC(C)C)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
CASP1 P29466 1/20 0.45
HTT P42858 1/20 0.43
HSD17B10 Q99714 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ADORA2A P29274 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ADRB2 P07550 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133496 0.92 KDM4E (0.54) KDM4EALOX15TSHRCASP1HTT
SCHEMBL6134162 0.90 MEN1 (0.51) KDM4EALOX15TSHRCASP1MEN1
SCHEMBL6134080 0.89 KDM4E (0.53) KDM4EALOX15TSHRCASP1HTT
SCHEMBL6133400 0.88 KDM4E (0.48) KDM4EALOX15TSHRCASP1HTT
SCHEMBL6133470 0.86 ALDH1A1 (0.47) KDM4EALOX15TSHRCASP1HTT
SCHEMBL6133574 0.86 HSD17B10 (0.46) KDM4ETSHRHTTHSD17B10MEN1
SCHEMBL6133813 0.85 ALOX15 (0.46) KDM4EALOX15TSHRCASP1HTT
SCHEMBL6133611 0.85 HTT (0.44) KDM4ETSHRHTTHSD17B10MEN1
SCHEMBL6133966 0.84 HTT (0.52) KDM4EHTTHSD17B10MEN1KMT2A
SCHEMBL6133518 0.84 USP2 (0.46) HTTHSD17B10ADORA2ASMN1; SMN2PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR KDM4E 3814/4885ALOX15 1491/4885TSHR 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.